An integrated knowledge database dedicated to ncRNAs, especially lncRNAs.

Detail infomation of NONHSAG001712.2

General info


NONCODE GENE IDNONHSAG001712.2
Chromosomechr1
Start Site64094441
End Site64171297
Strand-
Length3549
Assemblyhg38
ClassAntisense;
Other Gene VersionsNONHSAG001712.1(old version)

Transcripts in Gene


NONCODE TRANSCRIPT ID
NONHSAT003701.2
NONHSAT003702.2
NONHSAT003703.2
NONHSAT003704.2

Expression Profile (Data Source:Human Body Map)


adiposeadrenalbrainbrain_Rbreastcolon
0.785950.2163720.1116380.03609121.369060.301558
foreskinheartheart_RHLF_1HLF_2kidney
0.04918421.297230.04839410.03161250.08995740.281212
liverliver_RlunglymphNodeovaryplacenta_R
0.7065890.09184850.3118180.1013580.3825210.139345
prostateskeltalMuscletestestestes_RthyroidwhiteBloodCell
0.3813333.405840.2865420.02285270.8305230.166514
Loading...


Exosome Expression Profile (Data Source: NCBI GEO)


A431_cellLine
(Squamous Cell Carcinoma Cell Line Exosomes)
BJ_cellLine
(Foreskin Fibroblast Cell Line Exosomes)
HepG2_cellLine
(Hepatocellular Carcinoma Cell Line Exosomes)
HUVEC_cellLine
(Human Umbilical Vein Endothelial Cell Line Exosomes)
invasive_NFPAs
(Invasive Non-functional Pituitary Adenomas Exosomes)
02.940681.6242508.14262
non-invasive_NFPAs
(Non-invasive Non-functional Pituitary Adenomas Exosomes)
MCF7_cellLine
(Human Breast Cancer Cell Line Exosomes)
MDA-MB-231_cellLine
(Human Breast Cancer Cell Line Exosomes)
tuberculosis_patients_serum
(Active Tuberculosis Patients Serum Exosomes)
normal_people_blood
(Normal People Blood Exosomes)
9.76695006.67070
Loading...


Conservation Info


  • Chordata
    • Vertebrates
      • Manmals
        • Primates
        • Rodents
          • Mouse : N/A
          • Rat : N/A
        • Laurasiatheria
          • Pig : N/A
          • Cow : N/A
        • Opossum : N/A
        • Platypus : N/A
      • Birds
        • Chicken : N/A
    • Actinopteryqii
      • Zebrafish : N/A

Note: T = There are transcripts in this region.


Disease related


Disease:

NONCODE IDGene SymbolDisease nameSource DatabaseSource PMID

Mutations:

NONCODE IDSNP IDGWAS traitSource PMID
NONHSAG001712.2rs3933251Urinary bladder cancer19648920
NONHSAG001712.2rs3933251Bladder cancer19648920
NONHSAG001712.2rs942446Serum ratio of (ascorbate (Vitamin C))/(trigonelline (N'-methylnicotinate))21886157
NONHSAG001712.2rs2806541Urinary bladder cancer19648920
NONHSAG001712.2rs2806541Bladder cancer19648920
NONHSAG001712.2rs2806541Arthritis including non-Rheumatoid18668548
NONHSAG001712.2rs2806541Serum ratio of (ascorbate (Vitamin C))/(trigonelline (N'-methylnicotinate))21886157
NONHSAG001712.2rs2806541Longstanding arthritis18668548
NONHSAG001712.2rs7521771Serum ratio of (gamma-glutamylthreonine*)/(glycerophosphorylcholine (GPC))21886157
NONHSAG001712.2rs12036326Serum concentration of 1-linoleoylglycerol (1-monolinolein)21886157
NONHSAG001712.2rs35003102Gene expression of OR7G2 in peripheral blood monocytes20502693
NONHSAG001712.2rs35003102Serum concentration of theobromine21886157
NONHSAG001712.2rs2806535Serum ratio of (2-hydroxyacetaminophen sulfate*)/(4-acetaminophen sulfate)21886157
NONHSAG001712.2rs2806537Serum concentration of 1-arachidonoylglycerophosphoethanolamine*21886157
NONHSAG001712.2rs6677577Serum ratio of (1-palmitoylglycerol (1-monopalmitin))/(thromboxane B2)21886157
NONHSAG001712.2rs7546975Birth weight23202124
NONHSAG001712.2rs17357054Serum concentration of 1-arachidonoylglycerophosphoethanolamine*21886157
NONHSAG001712.2rs6682870Serum ratio of (4-vinylphenol sulfate)/(biliverdin)21886157
NONHSAG001712.2rs11808138Serum ratio of (4-vinylphenol sulfate)/(biliverdin)21886157
NONHSAG001712.2rs1408417Serum ratio of (biliverdin)/(theobromine)21886157
NONHSAG001712.2rs2762848Serum ratio of (biliverdin)/(theobromine)21886157
NONHSAG001712.2rs2762849Bipolar disorder and schizophrenia20889312
NONHSAG001712.2rs2762849Schizophrenia20889312
NONHSAG001712.2rs2762849Serum concentration of beta-hydroxyisovalerate21886157
NONHSAG001712.2rs10889464Gln-PTC / PC ae C40:420037589
NONHSAG001712.2rs10889464Serum ratio of (1-arachidonoylglycerophosphocholine*)/(2-methylbutyroylcarnitine)21886157
NONHSAG001712.2rs10889464PC ae C42:120037589
NONHSAG001712.2rs11583399PC ae C40:5 / Gln-PTC20037589
NONHSAG001712.2rs11583399PC aa C42:620037589
NONHSAG001712.2rs10489902PC ae C40:4 / Gln-PTC20037589
NONHSAG001712.2rs10489902PC aa C42:620037589
NONHSAG001712.2rs10489902Serum ratio of (beta-hydroxyisovalerate)/(pyroglutamylglycine)21886157
NONHSAG001712.2rs10489902Type 2 diabetes17846124
NONHSAG001712.2rs10489901Hypertriglyceridemia23505323
NONHSAG001712.2rs12025819Hearing function17255346
NONHSAG001712.2rs12025819Serum concentration of beta-hydroxyisovalerate21886157
NONHSAG001712.2rs12025819Gene expression of JAK1 [probe 201648_at] in prefrontal cortex20351726
NONHSAG001712.2rs11208366PC ae C40:4 / Gln-PTC20037589
NONHSAG001712.2rs11208366PC ae C42:120037589
NONHSAG001712.2rs11208366Serum ratio of (beta-hydroxyisovalerate)/(pyroglutamylglycine)21886157
NONHSAG001712.2rs11208367Gln-PTC / PC ae C40:420037589
NONHSAG001712.2rs11208367PC ae C42:120037589
NONHSAG001712.2rs6588083Schizophrenia19197363
NONHSAG001712.2rs6588083Schizophrenia19197363
NONHSAG001712.2rs12089614Serum concentration of gamma-glutamylphenylalanine21886157
NONHSAG001712.2rs4619008Serum ratio of (4-hydroxyphenylacetate)/(hydroxyisovaleroyl carnitine)21886157
NONHSAG001712.2rs12023447Serum ratio of (4-hydroxyphenylacetate)/(hydroxyisovaleroyl carnitine)21886157
NONHSAG001712.2rs3884549Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months)23233654
NONHSAG001712.2rs3884549Methotrexate clearance (acute lymphoblastic leukemia)23233662
NONHSAG001712.2rs3884549Parkinson's disease22451204
NONHSAG001712.2rs4915657Serum ratio of (10-heptadecenoate (17:1n7))/(oleoylcarnitine)21886157
NONHSAG001712.2rs4915657Appendicular lean mass-femoral neck cross-sectional area bivariate association22087292
NONHSAG001712.2rs4915657Methotrexate clearance (acute lymphoblastic leukemia)23233662
NONHSAG001712.2rs4915657Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months)23233654
NONHSAG001712.2rs4915657Parkinson's disease22451204
NONHSAG001712.2rs4915658Parkinson's disease22451204
NONHSAG001712.2rs4915658Methotrexate clearance (acute lymphoblastic leukemia)23233662
NONHSAG001712.2rs4915658Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months)23233654
NONHSAG001712.2rs7515058Major depressive disorder (narrow definition) (females)20038947
NONHSAG001712.2rs6676128Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months)23233654
NONHSAG001712.2rs6676128Methotrexate clearance (acute lymphoblastic leukemia)23233662
NONHSAG001712.2rs6676128Parkinson's disease22451204